Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists
Published inJournal of Thrombosis and Haemostasis, vol. 15, p. 2165-2175
Publication date2017
Abstract
Affiliation
Research group
Citation (ISO format)
NAGLER, M et al. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. In: Journal of Thrombosis and Haemostasis, 2017, vol. 15, p. 2165–2175. doi: 10.1111/jth.13810
Main files (1)
Article (Published version)
Identifiers
- PID : unige:99342
- DOI : 10.1111/jth.13810
- PMID : 28834238
ISSN of the journal1538-7836